Synergism exhibited by LTD4 and PAF receptor antagonists in decreasing antigen-induced airway microvascular leakage.
Wasserman
M A
MA
Department of Bronchopulmonary Research, Hoffmann-La Roche, Inc., Nutley, New Jersey 07110, USA.
Welton
A F
AF
Renzetti
L M
LM
D000818:Animals; D001980:Bronchi / Q000098:blood supply; D001993:Bronchodilator Agents / Q000494:pharmacology; D004357:Drug Synergism; D006168:Guinea Pigs; D007114:Immunization; D017998:Leukotriene D4 / Q000494:pharmacology*; D008168:Lung / Q000098:blood supply; D008297:Male; D008833:Microcirculation / Q000187:drug effects / Q000502:physiology*; D010047:Ovalbumin / Q000276:immunology; D010617:Phenanthridines / Q000494:pharmacology*; D010980:Platelet Membrane Glycoproteins / Q000037:antagonists & inhibitors*; D011652:Pulmonary Circulation / Q000187:drug effects* / Q000502:physiology; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D013189:SRS-A / Q000037:antagonists & inhibitors; D013844:Thiazoles / Q000494:pharmacology*; D014132:Trachea / Q000098:blood supply; D014227:Triazines / Q000494:pharmacology*
D001993:Bronchodilator Agents; D010617:Phenanthridines; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D013189:SRS-A; D013844:Thiazoles; D014227:Triazines; C039351:platelet activating factor receptor; C071318:Ro 24-4736; C071436:cinalukast; D017998:Leukotriene D4; D010047:Ovalbumin